BIOMAT Database Logo BIOMAT Database Logo

Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women. 2023

R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Department of Gynecology and Obstetrics, Jundiai School of Medicine, Jundiai, Brazil.

This study aimed to evaluate the efficacy and safety of oral ultra-low-dose continuous combination of 17β-estradiol (17β-E2) and norethisterone acetate (NETA) in postmenopausal Brazilian women. Postmenopausal women (age 45-60 years) with amenorrhea >12 months and intact uterus, with moderate to severe vasomotor symptoms, were included. The vasomotor symptoms and endometrial bleeding were evaluated by a daily diary for 24 weeks, and the women were assessed at baseline and endpoint. A total of 118 women were included. The group treated with 0.5 mg 17β-E2/0.1 mg NETA (n = 58) showed a percentage reduction of 77.1% in the frequency of vasomotor symptoms versus 49.9% in the placebo group (n = 60) (p = 0.0001). The severity score showed a reduction in the treatment group when compared to the placebo (p < 0.0001). The adverse events were comparable between the groups; however, in the 0.5 mg 17β-E2/0.1 mg NETA group there were more complaints of vaginal bleeding; despite that, in most cycles in both treatment groups, more than 80% of women experienced amenorrhea. The combination of 0.5 mg 17β-E2/0.1 mg NETA in a continuous combination regimen was shown to be effective in reducing the frequency and severity of vasomotor symptoms in Brazilian postmenopausal women.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077563 Norethindrone Acetate Acetate ester of norethindrone that is used as a long-term contraceptive (CONTRACEPTIVE AGENTS). Estr-4-en-3-one, 17-(acetyloxy)-17-ethynyl-, (17beta)-,Aygestin,Norethindrone Acetate, (17alpha)-(+-)-isomer,Norethindrone Acetate, (17alpha)-isomer,Norethisterone Acetate,Norlutate
D000568 Amenorrhea Absence of menstruation. Postpartum Amenorrhea,Amenorrhea, Postpartum,Postpartum Amenorrheas
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement

Related Publications

R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
February 2008, Climacteric : the journal of the International Menopause Society,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
April 2007, Climacteric : the journal of the International Menopause Society,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.
January 2007, Menopause (New York, N.Y.),
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
February 2010, Climacteric : the journal of the International Menopause Society,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women.
April 2014, Climacteric : the journal of the International Menopause Society,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
June 2007, Maturitas,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
January 2002, Menopause (New York, N.Y.),
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
January 2002, Menopause (New York, N.Y.),
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
The effects of low dose norethisterone on biochemical variables in postmenopausal women.
January 1999, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
R Bonassi Machado, and L de Melo Pompei, and E A P Nahas, and J Nahas-Neto, and L da Costa-Paiva, and S Y O Del Debbio, and M Badalotti, and M C O Wender, and A M Cruz
Endometrial safety of ultra-low-dose estradiol vaginal tablets.
October 2010, Obstetrics and gynecology,
Copied contents to your clipboard!